Assortment categories

Brief characteristics of the company

AID Genomics Limited is a genomic R&D Company and solution provider with a genomic laboratory based in Israel. AID focuses on precision medicines for cancers and infectious diseases. AID also has sales offices in Japan, US and other Asian countries. The majority shareholder of AID Genomics Limited is A.I.D. Partners, an investment group founded in 2007 in Hong Kong whose Chairman Mr. Kelvin Wu has managed over US$1.5 billion assets in Media, IT and Healthcare since its inception. Our other shareholder, www.Wilab.com, is one of the leading VCs in Japan. Our expertise was recognized by the Israeli government and was chosen by its MOH & MOD to build, operate, and maintain seven dedicated Covid-19 tests laboratories with a current capacity of 100,000 tests per day.